R1	AND Arg1:T3 Arg2:T2	
R2	Has_multiplier Arg1:T3 Arg2:T1	
R3	Has_qualifier Arg1:T3 Arg2:T4	
R4	Has_value Arg1:T6 Arg2:T5	
R5	Has_value Arg1:T7 Arg2:T8	
R6	AND Arg1:T9 Arg2:T7	
R7	Has_mood Arg1:T11 Arg2:T10	
R8	Has_value Arg1:T12 Arg2:T13	
R9	Has_temporal Arg1:T12 Arg2:T14	
T1	Multiplier 33 41	3 cycles
T2	Drug 47 57	bortezomib
T3	Procedure 64 81	induction regimen
T4	Qualifier 105 120	NCCN guidelines
T5	Value 131 165	no evidence of disease progression
T6	Measurement 180 193	IMWG criteria
T7	Measurement 295 325	criteria for a diagnosis of MM
T8	Value 287 290	all
T9	Condition 214 252	light chain and free light chain (FLC)
T10	Mood 379 390	eligible to
T11	Procedure 405 416	IRD regimen
T12	Measurement 419 479	Eastern Cooperative Oncology Group (ECOG) performance status
T13	Value 512 522	0, 1, or 2
T14	Temporal 523 544	at time of enrollment
